Trulieve Cannabis (TCNNF) Net Income towards Common Stockholders (2020 - 2026)

Trulieve Cannabis (TCNNF) recorded quarterly Net Income towards Common Stockholders of $2.4 million in Q1 2026, up 105.61% quarter-over-quarter from -$42.9 million in Q4 2025, and up 107.32% on a YoY basis from $1.2 million in Q1 2025.

Trulieve Cannabis (TCNNF) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Trulieve Cannabis' Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at $2.4 million for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders rose 107.32% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at -$81.1 million (up 50.81% YoY), while the FY2025 annual figure was -$116.4 million, up 24.97% from the prior year.
  • Net Income towards Common Stockholders was $2.4 million for Q1 2026 at Trulieve Cannabis, up from -$42.9 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $2.4 million in Q1 2026 to a low of -$403.8 million in Q2 2023.
  • Historically, Net Income towards Common Stockholders has averaged -$61.3 million across 5 years, with a median of -$32.9 million in 2025.
  • The sharpest annual moves came in 2023 and 2026: Net Income towards Common Stockholders plunged 1695.6% in 2023, then surged 107.32% in 2026.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$77.0 million in 2022, then surged by 56.61% to -$33.4 million in 2023, then tumbled by 78.83% to -$59.8 million in 2024, then gained by 28.25% to -$42.9 million in 2025, then jumped by 105.61% to $2.4 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $2.4 million (Q1 2026), -$42.9 million (Q4 2025), and -$26.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 366.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -92.12 Mn
10 Trulieve Cannabis - - 170.08 Mn 2.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.41 Mn
Dec 31, 2025 -42.90 Mn
Sep 30, 2025 -26.84 Mn
Jun 30, 2025 -13.78 Mn
Mar 31, 2025 -32.87 Mn
Dec 31, 2024 -59.79 Mn
Sep 30, 2024 -60.21 Mn
Jun 30, 2024 -12.03 Mn
Mar 31, 2024 -23.08 Mn
Dec 31, 2023 -33.43 Mn
Sep 30, 2023 -25.39 Mn
Jun 30, 2023 -403.85 Mn
Mar 31, 2023 -64.12 Mn
Dec 31, 2022 -77.04 Mn
Sep 30, 2022 -114.55 Mn
Jun 30, 2022 -22.49 Mn
Mar 31, 2022 -31.98 Mn
Dec 31, 2021 -71.54 Mn
Sep 30, 2021 18.62 Mn
Jun 30, 2021 40.88 Mn